HCA Healthcare, Inc. (HCA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 30B 60B 90B Q1 '14: 34.6B Q2 '14: 35.4B Q3 '14: 36.1B Q4 '14: 36.9B Q1 '15: 37.8B Q2 '15: 38.4B Q4 '17: 43.6B Q1 '18: 44.4B Q2 '18: 45.2B Q3 '18: 46B Q4 '18: 46.7B Q1 '19: 47.8B Q2 '19: 48.8B Q3 '19: 50.1B Q4 '19: 51.3B Q1 '20: 51.7B Q2 '20: 50.1B Q3 '20: 50.8B Q4 '20: 51.5B Q1 '21: 52.6B Q2 '21: 56B Q3 '21: 58B Q4 '21: 58.8B Q1 '22: 59.7B Q2 '22: 60.1B Q3 '22: 59.8B Q4 '22: 60.2B Q1 '23: 60.9B Q2 '23: 61.9B Q3 '23: 63.2B Q4 '23: 65B Q1 '24: 66.7B Q2 '24: 68.3B Q3 '24: 69.6B Q4 '24: 70.6B Q1 '25: 71.6B Q2 '25: 72.7B Q3 '25: 74.4B Q4 '25: 75.6B Q1 '26: 76.4B Q1 '15 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income TTM

0 2.5B 5B 7.5B Q2 '16: 2.4B Q3 '16: 2.6B Q4 '16: 2.9B Q1 '17: 2.9B Q2 '17: 2.9B Q3 '17: 2.7B Q4 '17: 2.2B Q1 '18: 2.7B Q2 '18: 2.9B Q3 '18: 3.2B Q4 '18: 3.8B Q1 '19: 3.7B Q2 '19: 3.6B Q3 '19: 3.5B Q4 '19: 3.5B Q1 '20: 3B Q2 '20: 3.3B Q3 '20: 3.4B Q4 '20: 3.8B Q1 '21: 4.6B Q2 '21: 5B Q3 '21: 6.6B Q4 '21: 7B Q1 '22: 6.8B Q2 '22: 6.5B Q3 '22: 5.4B Q4 '22: 5.6B Q1 '23: 5.7B Q2 '23: 5.8B Q3 '23: 5.7B Q4 '23: 5.2B Q1 '24: 5.5B Q2 '24: 5.7B Q3 '24: 5.9B Q4 '24: 5.8B Q1 '25: 5.8B Q2 '25: 6B Q3 '25: 6.3B Q4 '25: 6.8B Q1 '26: 6.8B Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

0 6B 12B 18B Q2 '15: 4.8B Q3 '15: 4.8B Q4 '15: 4.7B Q1 '16: 5.1B Q2 '16: 5.4B Q3 '16: 5.5B Q4 '16: 5.7B Q1 '17: 5.5B Q2 '17: 5.6B Q3 '17: 5.4B Q4 '17: 5.4B Q1 '18: 5.4B Q2 '18: 5.6B Q3 '18: 6.3B Q4 '18: 6.8B Q1 '19: 6.5B Q2 '19: 6.9B Q3 '19: 7.3B Q4 '19: 7.6B Q1 '20: 8B Q2 '20: 14.7B Q3 '20: 15.3B Q4 '21: 9B Q1 '22: 8.3B Q2 '22: 7.7B Q3 '22: 8.4B Q4 '22: 8.5B Q1 '23: 9B Q2 '23: 9.8B Q3 '23: 9.3B Q4 '23: 9.4B Q1 '24: 10.1B Q2 '24: 9.6B Q3 '24: 10.6B Q4 '24: 10.5B Q1 '25: 9.7B Q2 '25: 11.9B Q3 '25: 12.8B Q4 '25: 12.6B Q1 '26: 13B Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q2 '22 Q3 '23 Q4 '24 Q1 '26

Free Cash Flow TTM

0 5B 10B 15B Q2 '15: 2.6B Q3 '15: 2.5B Q4 '15: 2.4B Q1 '16: 2.7B Q2 '16: 2.9B Q3 '16: 2.8B Q4 '16: 2.9B Q1 '17: 2.7B Q2 '17: 2.7B Q3 '17: 2.5B Q4 '17: 2.4B Q1 '18: 2.3B Q2 '18: 2.3B Q3 '18: 2.9B Q4 '18: 3.2B Q1 '19: 2.8B Q2 '19: 3.1B Q3 '19: 3.2B Q4 '19: 3.4B Q1 '20: 3.8B Q2 '20: 10.7B Q3 '20: 12B Q4 '21: 5.4B Q1 '22: 4.5B Q2 '22: 3.7B Q3 '22: 4.2B Q4 '22: 4.1B Q1 '23: 4.2B Q2 '23: 4.9B Q3 '23: 4.4B Q4 '23: 4.7B Q1 '24: 5.4B Q2 '24: 4.9B Q3 '24: 5.9B Q4 '24: 5.6B Q1 '25: 4.9B Q2 '25: 7.3B Q3 '25: 8.1B Q4 '25: 7.7B Q1 '26: 7.9B Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q2 '22 Q3 '23 Q4 '24 Q1 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 200M 400M 600M Q1 '13: 462.4M Q2 '13: 463.2M Q3 '13: 463.6M Q1 '14: 457.4M Q2 '14: 453M Q3 '14: 447.3M Q1 '15: 435.3M Q2 '15: 429.4M Q3 '15: 426.4M Q1 '16: 410.6M Q2 '16: 398.7M Q3 '16: 389.6M Q1 '17: 380M Q2 '17: 375.3M Q3 '17: 369.8M Q1 '18: 359.7M Q2 '18: 355M Q3 '18: 353.6M Q1 '19: 350.3M Q2 '19: 348.4M Q3 '19: 347.5M Q1 '20: 344.1M Q2 '20: 341.6M Q3 '20: 343.3M Q1 '21: 343.3M Q2 '21: 332.6M Q3 '21: 324M Q1 '22: 307.4M Q2 '22: 296.1M Q3 '22: 289.9M Q1 '23: 281M Q2 '23: 278.2M Q3 '23: 275.4M Q1 '24: 268M Q2 '24: 264.1M Q3 '24: 259.9M Q1 '25: 249.4M Q2 '25: 241.9M Q3 '25: 236.2M Q1 '26: 226.7M Q2 '14 Q1 '16 Q3 '17 Q2 '19 Q1 '21 Q3 '22 Q2 '24 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 10.00 20.00 30.00 Q2 '16: 5.79 Q3 '16: 6.33 Q4 '16: 7.32 Q1 '17: 7.37 Q2 '17: 7.47 Q3 '17: 7.03 Q4 '17: 5.94 Q1 '18: 7.38 Q2 '18: 7.94 Q3 '18: 8.94 Q4 '18: 10.65 Q1 '19: 10.44 Q2 '19: 10.38 Q3 '19: 9.99 Q4 '19: 10.07 Q1 '20: 8.79 Q2 '20: 9.70 Q3 '20: 9.89 Q4 '20: 10.94 Q1 '21: 13.39 Q2 '21: 14.59 Q3 '21: 19.64 Q4 '21: 21.23 Q1 '22: 21.23 Q2 '22: 20.77 Q3 '22: 17.68 Q4 '22: 19.13 Q1 '23: 19.84 Q2 '23: 20.23 Q3 '23: 20.23 Q4 '23: 18.95 Q1 '24: 20.03 Q2 '24: 21.27 Q3 '24: 22.24 Q4 '24: 21.97 Q1 '25: 22.49 Q2 '25: 23.79 Q3 '25: 25.87 Q4 '25: 28.34 Q1 '26: 29.04 Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.